SlideShare une entreprise Scribd logo
1  sur  74
Télécharger pour lire hors ligne
Board meeting
2-3 December 2015
CEO Board presentation
Seth Berkley MD
2nd December 2015
Geneva
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
Gavi’s involvement
THE
BIGGER
PICTURE
Board meeting
2-3 December 2015
UN Sustainable Development Summit, Sep 2015
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
Board meeting
2-3 December 2015
From MDGs 4, 5 and 6 to new global health goal
Ensure healthy lives and promote well-being for all at all ages
• Target 3.2: ...end preventable deaths of … children under 5 years
• Target 3.8: Achieve UHC … access to quality essential health-care
services and to safe, effective, quality and affordable essential
medicines and vaccines for all
• Target 3b: Support the research and development of vaccines
….provide access to affordable essential medicines and vaccines…
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
Board meeting
2-3 December 2015
Gavi proposes vaccine indicator
• Based on the Global Vaccine Action Plan:
“Reach and sustain 90% national coverage and 80% in every
district with all vaccines in national programmes”
• Decision expected: March 2016
The Board was shocked
to learn that the perhaps
single most relevant
indicator in the health
sector, immunisation
coverage, is not currently
being considered as an
individual item in the SDG
monitoring framework.
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
Board meeting
2-3 December 2015
12.7
MDG4: Reduce child mortality by two-thirds
1990 2015
5.9
MDG4
target4.2
Number of
children dying
under 5 years
old (millions)
17.5
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
Board meeting
2-3 December 2015
Gavi recognised as successful financing model:
“We will support relevant initiatives, such as Gavi, the Vaccine
Alliance....
“...existing mechanisms, such as the International Finance Facility
for Immunisation, might be replicated to address broader
development needs.”
Financing the Global Goals:
Addis Ababa Action Agenda, July 2015
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
Board meeting
2-3 December 2015
Sources: More than 4 million refugees in 2014, Jornal de Notícias; UNHCR Global Trends 2014
Diseases
know no
borders
Migration:
top 10 destinations for refugees
Developing regions host 86% of world’s refugees
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
Board meeting
2-3 December 2015
Ebola: focus on global health security
• Five global reviews on global
health preparedness
• Vaccines an important part of
the discussion: “An
international vaccine
development fund is urgently
needed [to] avert a repetition
of the Ebola crisis.”
7 Nov
Sierra Leone declared Ebola free
End Nov
Three new cases in Liberia
Today
Guinea, 4 weeks to go
Liberia
declared
Ebola free
Liberia
declared
Ebola free
Sierra
Leone
declared
Ebola free
Extracted from “CDC's Response to Ebola” 2014-2015, updated with WHO data until Nov 2015.
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
Board meeting
2-3 December 2015
Less than 1/3 of the world is prepared to respond
to outbreaks
By 2012 deadline, < 20% of countries met core capacity
requirements under WHO International Health Regulations
Source: Report to the Director-General
of the Review Committee on Second
Extensions for Establishing National
Public Health Capacities and on IHR
Implementation, November 2014
By 2014, this
had only increased
to 30%
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
Only 13/73 Gavi
countries have achieved
75% of requirements for
preparedness, response,
surveillance and labs
Board meeting
2-3 December 2015
Continued resurgence of measles
Data in WHO HQ as of 9 November 2015
US: big outbreak -
first measles death in
12 years, July
Australia: outbreak in
Aug-Sept
China: ~ 40,000 cases
Jan-Sept
DR Congo: ~ 20,000
cases Jan-Sept
0(49 countries or 25%)
1 - 9(29 countries or 15%)
10 - 99(45 countries or 23%)
100 - 999(30 countries or 15%)
≥1000(10 countries or 5%)
No data reported to WHO HQ(31 countries or 16%)
Not applicable
Number of cases
Number of reported measles cases with onset date from Apr 2015 to Sep 2015
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
Board meeting
2-3 December 2015
Boost routine immunisation
to eliminate measles
• Coverage: DTP3 has increased but measles flat-lining
• Routine immunisation: only half of children get 2nd dose
measles vaccine through routine system
• Coordination: need more cohesive approach with routine
immunisation at the core
Coverage in Gavi-supported countries
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
Source: WHO/UNICEF Estimates of National
Immunization Coverage, 2015.
Board meeting
2-3 December 2015
Looking back:
Wild poliovirus cases May-October 2011
Endemic country
Wild virus type 1
Country with
importation case
Wild virus type 3
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
Board meeting
2-3 December 2015
Data in WHO HQ as
of 31 October 2011
Board meeting
2-3 December 2015
1 Excludes viruses detected from
environmental surveillance
2 Onset of paralysis 18 May – 17
November 2015
Data in WHO HQ as
of 17 November 2015
Wild poliovirus cases1, May-November 20152
Nigeria no longer
polio endemic
Africa on its way to
becoming polio-free
Endemic country
Wild poliovirus type 1
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
Board meeting
2-3 December 2015
Board meeting
2-3 December 2015
cVDPV type 1
cVDPV type 2
1 Excludes viruses detected from
environmental surveillance.
2 Onset of paralysis 18 May – 17
November 2015
cVDPV cases1, May-November 20152
Endemic country
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
Board meeting
2-3 December 2015
Data in WHO HQ as
of 17 November 2015
Board meeting
2-3 December 2015
Number of Gavi-supported countries that have introduced IPV
IPV introduction delays but SAGE still
recommends April switch to bivalent OPV
Objective set by
Board in Nov 2013
Actual/projected country
introductions of IPV
Current status:
34 introductions
Target set in
Nov 2013
SwitchtOPV/bOPV
~ 19 countries
to introduce
after the switch
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
Board meeting
2-3 December 2015
How polio resources can help
strengthen routine immunisation
• People: experienced public health workers, social mobilisers, volunteers
• Outreach: have access to hard-to-reach households
• Planning: maps and micro-plans to reach neglected communities
• Data and surveillance: monitoring and analysis, real-time global
surveillance, GIS and response capacity
Gavi: proposed way forward
• No capacity/mandate to take over partners’ human resource networks
• Country-driven, country-specific approach
• Integrated in national programmes
• Focus on equitable and sustainable immunisation coverage
• Health system strengthening and Partners’ Engagement Framework key
instruments for support
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
GAVI UPDATES
Board meeting
2-3 December 2015
Board Chair-elect: Ngozi Okonjo-Iweala
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
Board meeting
2-3 December 2015
New contribution from the Republic of Korea
“Health and children are a priority for Korea’s development cooperation
policy and Gavi is our partner.”
Lee Yongsoo, Director-General Development Cooperation
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
Board meeting
2-3 December 2015
A more diverse financial base
Donor pledges
London, 2011
Donor pledges
Berlin, 2015
Other
2%
9 donors
29%
US$ 1.25 bn
3 donors
69%
US$ 4.345
billion
Other
3%
9 donors
43%
US$ 3.25 bn 3 donors
54%
US$ 7.539
billion
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
Board meeting
2-3 December 2015
2002 2004 2006 2008 2010 2012 2014 2016 2018 2020
Germany
Examples of donor growth
0
1,000
800
600
400
200
European
Commission
Republic
of Korea
Cumulativecontributions(US$millions)
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
Board meeting
2-3 December 2015
Visiting Ethiopia with DFID and the Global Fund,
July 2015
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
Board meeting
2-3 December 2015
Fifth award for IFFIm Sukuk, October 2015
Islamic Finance
Deal of the Year
Global Finance Magazine
Previous Sukuk awards:
• Financial Times’ Achievement in International Finance Award
• Islamic Finance News’ Social Impact Deal of the Year 2014
• EMEA Finance’s Best Supranational Sukuk
• Euromoney’s Innovation in Islamic Finance
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
Board meeting
2-3 December 2015
Vaccine introductions
Afghanistan: inactivated polio vaccine
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
Board meeting
2-3 December 2015
Vaccine introductions
Pakistan: inactivated polio vaccine
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
Board meeting
2-3 December 2015
Vaccine introductions
Papua New Guinea:
measles-rubella vaccine + IPV
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
Board meeting
2-3 December 2015
Nigeria (Northern states):
measles vaccine campaign
Vaccine introductions
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
Board meeting
2-3 December 2015
Vaccine introductions
Uganda: HPV national
introduction
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
Board meeting
2-3 December 2015
Vaccine introductions
Eritrea: pneumococcal vaccine
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
Board meeting
2-3 December 2015
Vaccine-type invasive pneumococcal disease
incidence in children under 2, the Gambia
Before and after pneumococcal vaccine introduction (PCV13)
0
50
100
150
200
250
Before PCV13
(2008-2010)
After PCV13
(2013-2014)
Incidenceper100,000population
82%
Reduction
Mackenzie GA et al. Impact of the Introduction of Pneumococcal Conjugate Vaccination on Invasive Pneumococcal
Disease in The Gambia: Population-Based Surveillance. Lancet Infectious Diseases, under review.
Note - other age groups available: 2-4 years, 5-14 years, >15 years; also: PCV7 type only, PCV 13 type only,
NVT, and all-type. Data here (PCV13 type , under 2) show highest impact.
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
Board meeting
2-3 December 2015
Hospital admissions for diarrhoea before and
after rotavirus vaccine introduction, Rwanda
Ngabo F et al. Effect of pentavalent rotavirus vaccine introduction on hospital admissions for
diarrhea and rotavirus in children in Rwanda: a time-series analysis. Lancet Global Health, in press.
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
Board meeting
2-3 December 2015
Vaccine stockpiles
Cameroon: first Gavi-funded
doses from OCV stockpile
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
Board meeting
2-3 December 2015
Vaccine stockpiles
Niger: meningitis A,C,Y,W
conjugate vaccine stockpile
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
2011-2015
RESULTS
Board meeting
2-3 December 2015
Mission indicators
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
Board meeting
2-3 December 2015
Vaccine goal indicators: country introductions
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
Board meeting
2-3 December 2015
15
28
57
Vaccine goal indicators: coverage
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
Board meeting
2-3 December 2015
Health systems goal indicators
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
Board meeting
2-3 December 2015
All key performance indicators available online
www.gavi.org/results/goal-level-indicators/
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
Board meeting
2-3 December 2015
First four countries transitioning from Gavi
support, 31 December 2015
Honduras
Sri Lanka
Bhutan
Mongolia
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
2016–2020:
REACHING EVERY
CHILD
Board meeting
2-3 December 2015
Our main tasks 2016-2020
 Maintain momentum of vaccine introductions
 Increase coverage and equity
 Strengthen routine immunisation
 Ensure sustainability
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
Board meeting
2-3 December 2015
Finish the job: continued focus on vaccine
introductions
2011 2012 2013 2014 2015
>220 introductions
20162017 2018 2019 2020
>220 introductions
Sources: Vaccine Implementation data as of 15 September 2015. Unconstrained introduction dates used
for all vaccines except yellow fever and rotavirus vaccines.
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
Board meeting
2-3 December 2015
Immunisation coverage in 73 Gavi-supported
countries
Coverage with three doses of DTP-containing vaccine
Source: WHO/UNICEF Estimates of National Immunization Coverage, 2015.
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
Board meeting
2-3 December 2015
A closer look
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
Board meeting
2-3 December 2015
100%
Measles-containing vaccine
1st dose
Pentavalent vaccine
Measles-containing vaccine
2nd dose
Yellow fever vaccinea
Pneumococcal vaccine
Rotavirus vaccine
Rubella vaccine
HPV vaccineb
Coverage by vaccine (%)
Immunisation coverage in Gavi-supported countries
Coverage refers to the final dose of each vaccine, unless otherwise stated.
a Target population and coverage estimates are based on 32 yellow fever-endemic Gavi-supported countries in Africa.
b Target population for HPV is 10 year old girls.
Source: Gavi strategic demand forecast version 12.
70
77
45
83
86
56
80
51
21
20
2
72
48
53
39
79
by 2015 by 2020
Projections
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
Board meeting
2-3 December 2015
17 countries
13 countries
4 countries
14 countries
11 countries
12 countries
< 50% 50-59% 60-69% 70-79% 80-89% > 90%
Routine immunisation coverage has
increased rapidly in many Gavi countries
1999 2004 2009 2014
Routine immunisation coverage
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
Board meeting
2-3 December 2015
8 countries
5 countries
13 countries
15 countries 15 countries
16 countries
< 50% 50-59% 60-69% 70-79% 80-89% > 90%
Routine immunisation coverage has
increased rapidly in many Gavi countries
1999 2004 2009 2014
Routine immunisation coverage
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
Board meeting
2-3 December 2015
3 countries
2 countries
6 countries
16 countries
17 countries
28 countries
< 50% 50-59% 60-69% 70-79% 80-89% > 90%
Routine immunisation coverage has
increased rapidly in many Gavi countries
1999 2004 2009 2014
Routine immunisation coverage
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
Board meeting
2-3 December 2015
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
< 50% 50-59% 60-69% 70-79% 80-89% > 90%
5 countries
2 countries
4 countries
14 countries
16 countries
32 countries
Routine immunisation coverage has
increased rapidly in many Gavi countries
1999 2004 2009 2014
Routine immunisation coverage
Board meeting
2-3 December 2015
< 50% 50-59% 60-69% 70-79% 80-89% > 90%
“Ceiling effect” as coverage increases
Routine immunisation coverage
20
15
10
5
0
25
Average%changein5yearperiod
Average percentage point change in five-year period by baseline
coverage level, third dose DTP-containing vaccine
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
Board meeting
2-3 December 2015
New country-focused approach to deliver on our
strategy, 2016-2020
Aligned,
integrated and
holistic package
of support for
countries
Partners’
Engagement
Framework
including
targeted country
assistance
Prioritisation:
intensified focus
on 20 countries
Cross-cutting
strategic focus
areas
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
Board meeting
2-3 December 2015
20 priority countries
Representing 75%
of under-immunised
children in Gavi
countries
10 countries
most under-immunised children
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
10 countries
high inequities1 or conflict
1 High inequity is
defined as >20%
coverage difference
between highest
and lowest wealth
quintile in DHS
surveys after 2010.
N/A
Board meeting
2-3 December 2015
Priority country: India
• Coverage: world’s largest number of under-immunised
children
• Equity: poorest states have similar income levels to poorest
Gavi-supported countries
• Catalytic partnership to launch pneumococcal, rotavirus,
rubella, human papillomavirus vaccines
“India’s rich experience in universal immunization and
particularly its experience this year with the Mission
Indradhanush could be shared with all countries.”
-- Narendra Modi, Indian Prime Minister
Mission Indradhanush: building on Gavi HSS grant to
mainstream polio resources into routine immunisation
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
Board meeting
2-3 December 2015
Gavi’s investment per child in the 15 Gavi-
eligible countries with the biggest birth cohorts
-
50
100
150
200
250
300
0 500,000 1,000,000 1,500,000 2,000,000 2,500,000 3,000,000 3,500,000 4,000,000 4,500,000
Children under-immunised with DTP3 in 2014
Gaviinvestmentperchild(US$)
India
Nigeria
Pakistan
Indonesia
Ethiopia
Congo, DR
Kenya
Afghanistan
Tanzania
Bangladesh
Angola
Sudan (the)
Uganda
Mozambique
Vietnam
Board meeting
2-3 December 2015
Priority country: Madagascar
Intensification of activities for coverage & equity
Supply chain
Human
resources
Service
delivery &
community
Data &
planning Financing
Rapid
deployment of
solar-drive
fridges in all
health centres
Increased staffing
in Centres de
Santé de Base
Health worker
training
Outreach and
micro-planning
Community
mobilisation
through health
workers
Increased
availability of
data collection
tools (registries,
vaccination
cards)
Redesigned data
flow
Advocating for
sufficient
financing
ISSUESSOLUTIONS
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
Board meeting
2-3 December 2015
Technical assistance
package
Application
guidelines
Technology guide for
decision makers
Advocacy and
communications
5-10 countries expected to apply in 2016 (NOT EXHAUSTIVE)
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
Cold Chain Equipment Platform:
launch preparations
Board meeting
2-3 December 2015
Vaccine-
preventable disease
surveillance
Proposed approach to data: what the
Alliance aims to achieve by 2020
Goals for
2020
Focus
areas
Strengthen country
surveillance systems &
create networks
Identify AEFI & investigate,
respond efficiently and
effectively and address
public concerns
Improve the availability,
quality, use of data &
strengthen health
workforce data use
capability
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
Data for
Immunisation
Delivery, Coverage
& Equity (DCE)
Vaccine safety
Board meeting
2-3 December 2015
Sustainability: 21 countries in accelerated
transition phase
Countries in accelerated transition phase
Set to become fully self-financing
from 2016Note: Cuba and the Ukraine
are no longer receiving Gavi vaccine support.
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
DELIVERING ON
THE NEW
STRATEGY
Alliance gearing up
Board meeting
2-3 December 2015
Improving the way we work: examples
• Risk management: new organisational structure, dedicated risk
function, new Head of Risk
• Knowledge management: country portal facilitating communications
between countries and partners
• Simplification: eg revised programme funding policy
• Grant management: streamlining disbursement and review
processes
• Human resources: performance and talent management
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
Board meeting
2-3 December 2015
Streamlining Board documentation
June 2015:
608 pages + 9 additional
documents on myGavi
December 2015:
466 pages, no additional
documents on myGavi
myGavi: not just Board meeting
documents and presentations, but also:
• Up-to-date calendar of all Board and
Board Committee meetings
• Up-to-date list of all Board and Board
Committee members
• Statutes, by-laws and committee
charters
• Board member reference book
• Policy handbook
• Quarterly risk report and risk register
Board meeting
2-3 December 2015
Partners’ Engagement Framework in action:
Afghanistan
• Enhanced national capacity: 4 of 6 national officers moved from
partner offices to health ministry
• Stronger alignment: less duplication between partners, more
harmonised support
• More transparent: country has visibility on Gavi-funded support
(limited insight into partners’ submissions)
• More targeted: added support from new partner to build financial
management capacity (country priority)
• Increased value for money: 23% reduction in budget with reduced
spend on travel and consulting
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
Board meeting
2-3 December 2015
Strengthened grant management:
responding to Yemen crisis
• Tailoring support to countries
• Re-allocation: HSS funds
rapidly re-allocated to support
integrated outreach
• Result: 1,900 mobile teams
reached 70,000 children in
September
• Going forward: continued use
of funds for integrated outreach,
channelled through partners
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
Board meeting
2-3 December 2015
Gavi recognised for country engagement
A Snapshot of Development Partner Communication
and Performance (October 2015)
Based on interviews with 6,750 policymakers and practitioners in 126
low- and middle-income countries
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
Board meeting
2-3 December 2015
Eight areas of potential collaboration
between Gavi and the Global Fund
BIGGER PICTURE RECENT UPDATES 2011-2015 RESULTS 2016-2020: RAISING OUR GAME GEARING UP
Programmes
Risk management
Supply chain
Non-vaccine
procurement
Monitoring, evaluation
& data
Resource mobilisation
Communications &
advocacy
Headquarters
operations
Board meeting
2-3 December 2015
Growing business: More proactive management
of programmes & risk
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
247
590
2011 2015
Number of doses
per year
(USD millions)
2x2
3
1
4
6
12
2011 2015
Number of vaccines
supported
2x
68
372
2011 2015
Cash grants disbursement
per year
(USD millions)
5x
150
470
2011 2015
Number of active grants
(vaccines and cash)
3x
Board meeting
2-3 December 2015
Board retreat in Beijing, China, April 2016
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
• dd
Board meeting
2-3 December 2015
Adapting to the frictionless economy
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
Board meeting
2-3 December 2015
Adapting to the frictionless economy?
BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
CHANGING
ROLES
Board meeting
2-3 December 2015
From President
Kikwete….
To private citizen
Kikwete….
Board meeting
2-3 December 2015
Special
Envoy
Høybråten

Contenu connexe

Tendances

Strategy update: indicators, progress and lessons learned
Strategy update: indicators, progress and lessons learnedStrategy update: indicators, progress and lessons learned
Strategy update: indicators, progress and lessons learnedGavi, the Vaccine Alliance
 
Gavi CEO presentation, Pledging Conference, Berlin 27 Jan 2015
Gavi CEO presentation, Pledging Conference, Berlin 27 Jan 2015Gavi CEO presentation, Pledging Conference, Berlin 27 Jan 2015
Gavi CEO presentation, Pledging Conference, Berlin 27 Jan 2015Gavi, the Vaccine Alliance
 
Recent Advances in Immunisation
Recent Advances in ImmunisationRecent Advances in Immunisation
Recent Advances in ImmunisationFahad Ahmad
 
Pentavalent: 1 vaccine to stop 5 diseases in 73 countries
Pentavalent: 1 vaccine to stop 5 diseases in 73 countriesPentavalent: 1 vaccine to stop 5 diseases in 73 countries
Pentavalent: 1 vaccine to stop 5 diseases in 73 countriesGavi, the Vaccine Alliance
 
Dr Seth Berkley, Gavi CEO, Mid-term review presentation
Dr Seth Berkley, Gavi CEO, Mid-term review presentationDr Seth Berkley, Gavi CEO, Mid-term review presentation
Dr Seth Berkley, Gavi CEO, Mid-term review presentationGavi, the Vaccine Alliance
 
Anuradha Gupta, Gavi DCEO, Mid-term review presentation
Anuradha Gupta, Gavi DCEO, Mid-term review presentationAnuradha Gupta, Gavi DCEO, Mid-term review presentation
Anuradha Gupta, Gavi DCEO, Mid-term review presentationGavi, the Vaccine Alliance
 
Introduction Of New Vaccines In The Public Market
Introduction Of New Vaccines In The Public MarketIntroduction Of New Vaccines In The Public Market
Introduction Of New Vaccines In The Public MarketStefano Malvolti
 
10.10 infection prevention and control ruth may
10.10 infection prevention and control   ruth may10.10 infection prevention and control   ruth may
10.10 infection prevention and control ruth mayNHS England
 

Tendances (20)

What Gavi can achieve 2016 2020
What Gavi can achieve 2016 2020What Gavi can achieve 2016 2020
What Gavi can achieve 2016 2020
 
CEO Board update June 2019
CEO Board update June 2019CEO Board update June 2019
CEO Board update June 2019
 
Strategy update: indicators, progress and lessons learned
Strategy update: indicators, progress and lessons learnedStrategy update: indicators, progress and lessons learned
Strategy update: indicators, progress and lessons learned
 
Gavi CEO presentation, Pledging Conference, Berlin 27 Jan 2015
Gavi CEO presentation, Pledging Conference, Berlin 27 Jan 2015Gavi CEO presentation, Pledging Conference, Berlin 27 Jan 2015
Gavi CEO presentation, Pledging Conference, Berlin 27 Jan 2015
 
Recent Advances in Immunisation
Recent Advances in ImmunisationRecent Advances in Immunisation
Recent Advances in Immunisation
 
Gavi CEO Board update, December 2019
Gavi CEO Board update, December 2019Gavi CEO Board update, December 2019
Gavi CEO Board update, December 2019
 
Pentavalent: 1 vaccine to stop 5 diseases in 73 countries
Pentavalent: 1 vaccine to stop 5 diseases in 73 countriesPentavalent: 1 vaccine to stop 5 diseases in 73 countries
Pentavalent: 1 vaccine to stop 5 diseases in 73 countries
 
Gavi CEO Board update, June 2020
Gavi CEO Board update, June 2020Gavi CEO Board update, June 2020
Gavi CEO Board update, June 2020
 
Gavi CEO Board update, December 2020
Gavi CEO Board update, December 2020Gavi CEO Board update, December 2020
Gavi CEO Board update, December 2020
 
The Gavi Investment Opportunity 2021-2025
The Gavi Investment Opportunity 2021-2025The Gavi Investment Opportunity 2021-2025
The Gavi Investment Opportunity 2021-2025
 
Strategy update
Strategy updateStrategy update
Strategy update
 
Gavi in 30 slides
Gavi in 30 slidesGavi in 30 slides
Gavi in 30 slides
 
Dr Seth Berkley, Gavi CEO, Mid-term review presentation
Dr Seth Berkley, Gavi CEO, Mid-term review presentationDr Seth Berkley, Gavi CEO, Mid-term review presentation
Dr Seth Berkley, Gavi CEO, Mid-term review presentation
 
Gavi UNECA Seth Berkley 040416
Gavi UNECA Seth Berkley 040416Gavi UNECA Seth Berkley 040416
Gavi UNECA Seth Berkley 040416
 
Gavi in 30 slides
Gavi in 30 slides Gavi in 30 slides
Gavi in 30 slides
 
Anuradha Gupta, Gavi DCEO, Mid-term review presentation
Anuradha Gupta, Gavi DCEO, Mid-term review presentationAnuradha Gupta, Gavi DCEO, Mid-term review presentation
Anuradha Gupta, Gavi DCEO, Mid-term review presentation
 
Antimicorbial resistance in the Eastern Mediterranean Region - English
Antimicorbial resistance in the Eastern Mediterranean Region - EnglishAntimicorbial resistance in the Eastern Mediterranean Region - English
Antimicorbial resistance in the Eastern Mediterranean Region - English
 
Introduction Of New Vaccines In The Public Market
Introduction Of New Vaccines In The Public MarketIntroduction Of New Vaccines In The Public Market
Introduction Of New Vaccines In The Public Market
 
10.10 infection prevention and control ruth may
10.10 infection prevention and control   ruth may10.10 infection prevention and control   ruth may
10.10 infection prevention and control ruth may
 
Hannah Kettler: "From Development to Delivery Globally: Case of Vaccines"
Hannah Kettler: "From Development to Delivery Globally: Case of Vaccines"Hannah Kettler: "From Development to Delivery Globally: Case of Vaccines"
Hannah Kettler: "From Development to Delivery Globally: Case of Vaccines"
 

Similaire à CEO Board report December 2015

ACHIEVEMENT AND PROGRESS TOWARDS HEALTH RELATED MDGS IN NEPAL
ACHIEVEMENT AND PROGRESS TOWARDS HEALTH RELATED MDGS IN NEPALACHIEVEMENT AND PROGRESS TOWARDS HEALTH RELATED MDGS IN NEPAL
ACHIEVEMENT AND PROGRESS TOWARDS HEALTH RELATED MDGS IN NEPALPublic Health Update
 
Immunisation in a digital world - Futures Workshop
Immunisation in a digital world - Futures WorkshopImmunisation in a digital world - Futures Workshop
Immunisation in a digital world - Futures WorkshopILC- UK
 
Post 2015 agenda & aids coordination
Post 2015 agenda & aids coordinationPost 2015 agenda & aids coordination
Post 2015 agenda & aids coordinationAIDS Watch Africa
 
Strategic Review: Towards a Grand Convergence for Child Survival and Health
Strategic Review: Towards a Grand Convergence for Child Survival and HealthStrategic Review: Towards a Grand Convergence for Child Survival and Health
Strategic Review: Towards a Grand Convergence for Child Survival and HealthCORE Group
 
Millenium development goals
Millenium development goalsMillenium development goals
Millenium development goalsDr.Hari Prakash
 
What Happened Since the Child Survival Call to Action_John Borazzo_4.26.13
What Happened Since the Child Survival Call to Action_John Borazzo_4.26.13What Happened Since the Child Survival Call to Action_John Borazzo_4.26.13
What Happened Since the Child Survival Call to Action_John Borazzo_4.26.13CORE Group
 
Progress, Challenges and Opportunities for Vaccines to Reduce Under-5 Childho...
Progress, Challenges and Opportunities for Vaccines to Reduce Under-5 Childho...Progress, Challenges and Opportunities for Vaccines to Reduce Under-5 Childho...
Progress, Challenges and Opportunities for Vaccines to Reduce Under-5 Childho...Sara Berlanda
 
Millenium development goals
Millenium development goalsMillenium development goals
Millenium development goalshariprakashdr
 
TRANSITION FROM MDG TO SDG.pdf
TRANSITION FROM MDG TO SDG.pdfTRANSITION FROM MDG TO SDG.pdf
TRANSITION FROM MDG TO SDG.pdfOsahon Otaigbe
 
PEPFAR overview of U.S. Presidents Emergency Plan for AIDS Relief
PEPFAR overview of U.S. Presidents Emergency Plan for AIDS ReliefPEPFAR overview of U.S. Presidents Emergency Plan for AIDS Relief
PEPFAR overview of U.S. Presidents Emergency Plan for AIDS Relief#GOMOJO, INC.
 
PBH101 Group Presentation on MGD-4 Reduce Child Mortality
PBH101 Group Presentation on MGD-4 Reduce Child MortalityPBH101 Group Presentation on MGD-4 Reduce Child Mortality
PBH101 Group Presentation on MGD-4 Reduce Child MortalityGaulib Haidar
 
philippines-slides-aug-2022.pptx
philippines-slides-aug-2022.pptxphilippines-slides-aug-2022.pptx
philippines-slides-aug-2022.pptxRusselOlivo
 
The GAVI Alliance
The GAVI AllianceThe GAVI Alliance
The GAVI AlliancePamoja
 
EC311 Global Economic Issues (Foreign Aid)
EC311 Global Economic Issues (Foreign Aid)EC311 Global Economic Issues (Foreign Aid)
EC311 Global Economic Issues (Foreign Aid)Ryan Herzog
 
ILC webinar: Under the microscope: Comparing countries’ experiences of the CO...
ILC webinar: Under the microscope: Comparing countries’ experiences of the CO...ILC webinar: Under the microscope: Comparing countries’ experiences of the CO...
ILC webinar: Under the microscope: Comparing countries’ experiences of the CO...ILC- UK
 
Regional Overview in HIV by Steve Kraus
Regional Overview in HIV by Steve KrausRegional Overview in HIV by Steve Kraus
Regional Overview in HIV by Steve KrausDr. Rubz
 
AIDSTAR-One Increasing Access to Prevention of Mother-to-Child Transmission S...
AIDSTAR-One Increasing Access to Prevention of Mother-to-Child Transmission S...AIDSTAR-One Increasing Access to Prevention of Mother-to-Child Transmission S...
AIDSTAR-One Increasing Access to Prevention of Mother-to-Child Transmission S...AIDSTAROne
 

Similaire à CEO Board report December 2015 (20)

ACHIEVEMENT AND PROGRESS TOWARDS HEALTH RELATED MDGS IN NEPAL
ACHIEVEMENT AND PROGRESS TOWARDS HEALTH RELATED MDGS IN NEPALACHIEVEMENT AND PROGRESS TOWARDS HEALTH RELATED MDGS IN NEPAL
ACHIEVEMENT AND PROGRESS TOWARDS HEALTH RELATED MDGS IN NEPAL
 
Immunisation in a digital world - Futures Workshop
Immunisation in a digital world - Futures WorkshopImmunisation in a digital world - Futures Workshop
Immunisation in a digital world - Futures Workshop
 
Post 2015 agenda & aids coordination
Post 2015 agenda & aids coordinationPost 2015 agenda & aids coordination
Post 2015 agenda & aids coordination
 
Strategic Review: Towards a Grand Convergence for Child Survival and Health
Strategic Review: Towards a Grand Convergence for Child Survival and HealthStrategic Review: Towards a Grand Convergence for Child Survival and Health
Strategic Review: Towards a Grand Convergence for Child Survival and Health
 
Millenium development goals
Millenium development goalsMillenium development goals
Millenium development goals
 
What Happened Since the Child Survival Call to Action_John Borazzo_4.26.13
What Happened Since the Child Survival Call to Action_John Borazzo_4.26.13What Happened Since the Child Survival Call to Action_John Borazzo_4.26.13
What Happened Since the Child Survival Call to Action_John Borazzo_4.26.13
 
Progress, Challenges and Opportunities for Vaccines to Reduce Under-5 Childho...
Progress, Challenges and Opportunities for Vaccines to Reduce Under-5 Childho...Progress, Challenges and Opportunities for Vaccines to Reduce Under-5 Childho...
Progress, Challenges and Opportunities for Vaccines to Reduce Under-5 Childho...
 
Millenium development goals
Millenium development goalsMillenium development goals
Millenium development goals
 
TRANSITION FROM MDG TO SDG.pdf
TRANSITION FROM MDG TO SDG.pdfTRANSITION FROM MDG TO SDG.pdf
TRANSITION FROM MDG TO SDG.pdf
 
PEPFAR overview of U.S. Presidents Emergency Plan for AIDS Relief
PEPFAR overview of U.S. Presidents Emergency Plan for AIDS ReliefPEPFAR overview of U.S. Presidents Emergency Plan for AIDS Relief
PEPFAR overview of U.S. Presidents Emergency Plan for AIDS Relief
 
Nutrition in the European Commission's External Assistance: Third Progress Re...
Nutrition in the European Commission's External Assistance: Third Progress Re...Nutrition in the European Commission's External Assistance: Third Progress Re...
Nutrition in the European Commission's External Assistance: Third Progress Re...
 
PBH101 Group Presentation on MGD-4 Reduce Child Mortality
PBH101 Group Presentation on MGD-4 Reduce Child MortalityPBH101 Group Presentation on MGD-4 Reduce Child Mortality
PBH101 Group Presentation on MGD-4 Reduce Child Mortality
 
philippines-slides-aug-2022.pptx
philippines-slides-aug-2022.pptxphilippines-slides-aug-2022.pptx
philippines-slides-aug-2022.pptx
 
The GAVI Alliance
The GAVI AllianceThe GAVI Alliance
The GAVI Alliance
 
EC311 Global Economic Issues (Foreign Aid)
EC311 Global Economic Issues (Foreign Aid)EC311 Global Economic Issues (Foreign Aid)
EC311 Global Economic Issues (Foreign Aid)
 
ILC webinar: Under the microscope: Comparing countries’ experiences of the CO...
ILC webinar: Under the microscope: Comparing countries’ experiences of the CO...ILC webinar: Under the microscope: Comparing countries’ experiences of the CO...
ILC webinar: Under the microscope: Comparing countries’ experiences of the CO...
 
Global polio updates and hss
Global polio updates and hssGlobal polio updates and hss
Global polio updates and hss
 
Regional Overview in HIV by Steve Kraus
Regional Overview in HIV by Steve KrausRegional Overview in HIV by Steve Kraus
Regional Overview in HIV by Steve Kraus
 
AIDSTAR-One Increasing Access to Prevention of Mother-to-Child Transmission S...
AIDSTAR-One Increasing Access to Prevention of Mother-to-Child Transmission S...AIDSTAR-One Increasing Access to Prevention of Mother-to-Child Transmission S...
AIDSTAR-One Increasing Access to Prevention of Mother-to-Child Transmission S...
 
Addressing the first 90: How can HIV testing more efficiently reach those in ...
Addressing the first 90: How can HIV testing more efficiently reach those in ...Addressing the first 90: How can HIV testing more efficiently reach those in ...
Addressing the first 90: How can HIV testing more efficiently reach those in ...
 

Plus de Gavi, the Vaccine Alliance (8)

Gavi en 30 diapositives
Gavi en 30 diapositivesGavi en 30 diapositives
Gavi en 30 diapositives
 
CEO Board update November 2018
CEO Board update November 2018CEO Board update November 2018
CEO Board update November 2018
 
Ola Rosling, President, Gapminder - Mid-term review presentation
Ola Rosling, President, Gapminder - Mid-term review presentationOla Rosling, President, Gapminder - Mid-term review presentation
Ola Rosling, President, Gapminder - Mid-term review presentation
 
Gavi en 30 diapositives
Gavi en 30 diapositivesGavi en 30 diapositives
Gavi en 30 diapositives
 
Gavi in 30 slides
Gavi in 30 slidesGavi in 30 slides
Gavi in 30 slides
 
Gavi en 30 diapositives
Gavi en 30 diapositivesGavi en 30 diapositives
Gavi en 30 diapositives
 
CEO Board update June 2018
CEO Board update June 2018CEO Board update June 2018
CEO Board update June 2018
 
CEO Board update 29 Nov 2017
CEO Board update  29 Nov 2017CEO Board update  29 Nov 2017
CEO Board update 29 Nov 2017
 

Dernier

Tans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxTans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxKezaiah S
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...sdateam0
 
Units of Radiation Measurements, Quality Specification, Half-Value Thickness,...
Units of Radiation Measurements, Quality Specification, Half-Value Thickness,...Units of Radiation Measurements, Quality Specification, Half-Value Thickness,...
Units of Radiation Measurements, Quality Specification, Half-Value Thickness,...Dr. Dheeraj Kumar
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Badalona Serveis Assistencials
 
Valproic Acid. (VPA). Antiseizure medication
Valproic Acid.  (VPA). Antiseizure medicationValproic Acid.  (VPA). Antiseizure medication
Valproic Acid. (VPA). Antiseizure medicationMohamadAlhes
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptxBibekananda shah
 
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfSGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfHongBiThi1
 
Phytochemical Investigation of Drugs PDF.pdf
Phytochemical Investigation of Drugs PDF.pdfPhytochemical Investigation of Drugs PDF.pdf
Phytochemical Investigation of Drugs PDF.pdfDivya Kanojiya
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!ibtesaam huma
 
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityCEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityHarshChauhan475104
 
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxPresentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxpdamico1
 
ANEMIA IN PREGNANCY by Dr. Akebom Kidanemariam
ANEMIA IN PREGNANCY by Dr. Akebom KidanemariamANEMIA IN PREGNANCY by Dr. Akebom Kidanemariam
ANEMIA IN PREGNANCY by Dr. Akebom KidanemariamAkebom Gebremichael
 
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)MohamadAlhes
 
World-Health-Day-2024-My-Health-My-Right.pptx
World-Health-Day-2024-My-Health-My-Right.pptxWorld-Health-Day-2024-My-Health-My-Right.pptx
World-Health-Day-2024-My-Health-My-Right.pptxEx WHO/USAID
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Mohamed Rizk Khodair
 
Systemic Lupus Erythematosus -SLE PT2.ppt
Systemic  Lupus  Erythematosus -SLE PT2.pptSystemic  Lupus  Erythematosus -SLE PT2.ppt
Systemic Lupus Erythematosus -SLE PT2.pptraviapr7
 
CCSC6142 Week 3 Research ethics - Long Hoang.pdf
CCSC6142 Week 3 Research ethics - Long Hoang.pdfCCSC6142 Week 3 Research ethics - Long Hoang.pdf
CCSC6142 Week 3 Research ethics - Long Hoang.pdfMyThaoAiDoan
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxDr. Dheeraj Kumar
 
Nutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience ClassNutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience Classmanuelazg2001
 

Dernier (20)

Tans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxTans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptx
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
 
Units of Radiation Measurements, Quality Specification, Half-Value Thickness,...
Units of Radiation Measurements, Quality Specification, Half-Value Thickness,...Units of Radiation Measurements, Quality Specification, Half-Value Thickness,...
Units of Radiation Measurements, Quality Specification, Half-Value Thickness,...
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
 
Valproic Acid. (VPA). Antiseizure medication
Valproic Acid.  (VPA). Antiseizure medicationValproic Acid.  (VPA). Antiseizure medication
Valproic Acid. (VPA). Antiseizure medication
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
 
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfSGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
 
Phytochemical Investigation of Drugs PDF.pdf
Phytochemical Investigation of Drugs PDF.pdfPhytochemical Investigation of Drugs PDF.pdf
Phytochemical Investigation of Drugs PDF.pdf
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!
 
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityCEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
 
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxPresentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
 
ANEMIA IN PREGNANCY by Dr. Akebom Kidanemariam
ANEMIA IN PREGNANCY by Dr. Akebom KidanemariamANEMIA IN PREGNANCY by Dr. Akebom Kidanemariam
ANEMIA IN PREGNANCY by Dr. Akebom Kidanemariam
 
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)
 
World-Health-Day-2024-My-Health-My-Right.pptx
World-Health-Day-2024-My-Health-My-Right.pptxWorld-Health-Day-2024-My-Health-My-Right.pptx
World-Health-Day-2024-My-Health-My-Right.pptx
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)
 
Systemic Lupus Erythematosus -SLE PT2.ppt
Systemic  Lupus  Erythematosus -SLE PT2.pptSystemic  Lupus  Erythematosus -SLE PT2.ppt
Systemic Lupus Erythematosus -SLE PT2.ppt
 
CCSC6142 Week 3 Research ethics - Long Hoang.pdf
CCSC6142 Week 3 Research ethics - Long Hoang.pdfCCSC6142 Week 3 Research ethics - Long Hoang.pdf
CCSC6142 Week 3 Research ethics - Long Hoang.pdf
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptx
 
Nutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience ClassNutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience Class
 

CEO Board report December 2015

  • 1. Board meeting 2-3 December 2015 CEO Board presentation Seth Berkley MD 2nd December 2015 Geneva BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
  • 3. Board meeting 2-3 December 2015 UN Sustainable Development Summit, Sep 2015 BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
  • 4. Board meeting 2-3 December 2015 From MDGs 4, 5 and 6 to new global health goal Ensure healthy lives and promote well-being for all at all ages • Target 3.2: ...end preventable deaths of … children under 5 years • Target 3.8: Achieve UHC … access to quality essential health-care services and to safe, effective, quality and affordable essential medicines and vaccines for all • Target 3b: Support the research and development of vaccines ….provide access to affordable essential medicines and vaccines… BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
  • 5. Board meeting 2-3 December 2015 Gavi proposes vaccine indicator • Based on the Global Vaccine Action Plan: “Reach and sustain 90% national coverage and 80% in every district with all vaccines in national programmes” • Decision expected: March 2016 The Board was shocked to learn that the perhaps single most relevant indicator in the health sector, immunisation coverage, is not currently being considered as an individual item in the SDG monitoring framework. BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
  • 6. Board meeting 2-3 December 2015 12.7 MDG4: Reduce child mortality by two-thirds 1990 2015 5.9 MDG4 target4.2 Number of children dying under 5 years old (millions) 17.5 BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
  • 7. Board meeting 2-3 December 2015 Gavi recognised as successful financing model: “We will support relevant initiatives, such as Gavi, the Vaccine Alliance.... “...existing mechanisms, such as the International Finance Facility for Immunisation, might be replicated to address broader development needs.” Financing the Global Goals: Addis Ababa Action Agenda, July 2015 BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
  • 8. Board meeting 2-3 December 2015 Sources: More than 4 million refugees in 2014, Jornal de Notícias; UNHCR Global Trends 2014 Diseases know no borders Migration: top 10 destinations for refugees Developing regions host 86% of world’s refugees BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
  • 9. Board meeting 2-3 December 2015 Ebola: focus on global health security • Five global reviews on global health preparedness • Vaccines an important part of the discussion: “An international vaccine development fund is urgently needed [to] avert a repetition of the Ebola crisis.” 7 Nov Sierra Leone declared Ebola free End Nov Three new cases in Liberia Today Guinea, 4 weeks to go Liberia declared Ebola free Liberia declared Ebola free Sierra Leone declared Ebola free Extracted from “CDC's Response to Ebola” 2014-2015, updated with WHO data until Nov 2015. BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
  • 10. Board meeting 2-3 December 2015 Less than 1/3 of the world is prepared to respond to outbreaks By 2012 deadline, < 20% of countries met core capacity requirements under WHO International Health Regulations Source: Report to the Director-General of the Review Committee on Second Extensions for Establishing National Public Health Capacities and on IHR Implementation, November 2014 By 2014, this had only increased to 30% BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP Only 13/73 Gavi countries have achieved 75% of requirements for preparedness, response, surveillance and labs
  • 11. Board meeting 2-3 December 2015 Continued resurgence of measles Data in WHO HQ as of 9 November 2015 US: big outbreak - first measles death in 12 years, July Australia: outbreak in Aug-Sept China: ~ 40,000 cases Jan-Sept DR Congo: ~ 20,000 cases Jan-Sept 0(49 countries or 25%) 1 - 9(29 countries or 15%) 10 - 99(45 countries or 23%) 100 - 999(30 countries or 15%) ≥1000(10 countries or 5%) No data reported to WHO HQ(31 countries or 16%) Not applicable Number of cases Number of reported measles cases with onset date from Apr 2015 to Sep 2015 BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
  • 12. Board meeting 2-3 December 2015 Boost routine immunisation to eliminate measles • Coverage: DTP3 has increased but measles flat-lining • Routine immunisation: only half of children get 2nd dose measles vaccine through routine system • Coordination: need more cohesive approach with routine immunisation at the core Coverage in Gavi-supported countries BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP Source: WHO/UNICEF Estimates of National Immunization Coverage, 2015.
  • 13. Board meeting 2-3 December 2015 Looking back: Wild poliovirus cases May-October 2011 Endemic country Wild virus type 1 Country with importation case Wild virus type 3 BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP Board meeting 2-3 December 2015 Data in WHO HQ as of 31 October 2011
  • 14. Board meeting 2-3 December 2015 1 Excludes viruses detected from environmental surveillance 2 Onset of paralysis 18 May – 17 November 2015 Data in WHO HQ as of 17 November 2015 Wild poliovirus cases1, May-November 20152 Nigeria no longer polio endemic Africa on its way to becoming polio-free Endemic country Wild poliovirus type 1 BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP Board meeting 2-3 December 2015
  • 15. Board meeting 2-3 December 2015 cVDPV type 1 cVDPV type 2 1 Excludes viruses detected from environmental surveillance. 2 Onset of paralysis 18 May – 17 November 2015 cVDPV cases1, May-November 20152 Endemic country BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP Board meeting 2-3 December 2015 Data in WHO HQ as of 17 November 2015
  • 16. Board meeting 2-3 December 2015 Number of Gavi-supported countries that have introduced IPV IPV introduction delays but SAGE still recommends April switch to bivalent OPV Objective set by Board in Nov 2013 Actual/projected country introductions of IPV Current status: 34 introductions Target set in Nov 2013 SwitchtOPV/bOPV ~ 19 countries to introduce after the switch BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
  • 17. Board meeting 2-3 December 2015 How polio resources can help strengthen routine immunisation • People: experienced public health workers, social mobilisers, volunteers • Outreach: have access to hard-to-reach households • Planning: maps and micro-plans to reach neglected communities • Data and surveillance: monitoring and analysis, real-time global surveillance, GIS and response capacity Gavi: proposed way forward • No capacity/mandate to take over partners’ human resource networks • Country-driven, country-specific approach • Integrated in national programmes • Focus on equitable and sustainable immunisation coverage • Health system strengthening and Partners’ Engagement Framework key instruments for support BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
  • 19. Board meeting 2-3 December 2015 Board Chair-elect: Ngozi Okonjo-Iweala BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
  • 20. Board meeting 2-3 December 2015 New contribution from the Republic of Korea “Health and children are a priority for Korea’s development cooperation policy and Gavi is our partner.” Lee Yongsoo, Director-General Development Cooperation BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
  • 21. Board meeting 2-3 December 2015 A more diverse financial base Donor pledges London, 2011 Donor pledges Berlin, 2015 Other 2% 9 donors 29% US$ 1.25 bn 3 donors 69% US$ 4.345 billion Other 3% 9 donors 43% US$ 3.25 bn 3 donors 54% US$ 7.539 billion BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
  • 22. Board meeting 2-3 December 2015 2002 2004 2006 2008 2010 2012 2014 2016 2018 2020 Germany Examples of donor growth 0 1,000 800 600 400 200 European Commission Republic of Korea Cumulativecontributions(US$millions) BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
  • 23. Board meeting 2-3 December 2015 Visiting Ethiopia with DFID and the Global Fund, July 2015 BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
  • 24. Board meeting 2-3 December 2015 Fifth award for IFFIm Sukuk, October 2015 Islamic Finance Deal of the Year Global Finance Magazine Previous Sukuk awards: • Financial Times’ Achievement in International Finance Award • Islamic Finance News’ Social Impact Deal of the Year 2014 • EMEA Finance’s Best Supranational Sukuk • Euromoney’s Innovation in Islamic Finance BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
  • 25. Board meeting 2-3 December 2015 Vaccine introductions Afghanistan: inactivated polio vaccine BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
  • 26. Board meeting 2-3 December 2015 Vaccine introductions Pakistan: inactivated polio vaccine BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
  • 27. Board meeting 2-3 December 2015 Vaccine introductions Papua New Guinea: measles-rubella vaccine + IPV BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
  • 28. Board meeting 2-3 December 2015 Nigeria (Northern states): measles vaccine campaign Vaccine introductions BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
  • 29. Board meeting 2-3 December 2015 Vaccine introductions Uganda: HPV national introduction BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
  • 30. Board meeting 2-3 December 2015 Vaccine introductions Eritrea: pneumococcal vaccine BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
  • 31. Board meeting 2-3 December 2015 Vaccine-type invasive pneumococcal disease incidence in children under 2, the Gambia Before and after pneumococcal vaccine introduction (PCV13) 0 50 100 150 200 250 Before PCV13 (2008-2010) After PCV13 (2013-2014) Incidenceper100,000population 82% Reduction Mackenzie GA et al. Impact of the Introduction of Pneumococcal Conjugate Vaccination on Invasive Pneumococcal Disease in The Gambia: Population-Based Surveillance. Lancet Infectious Diseases, under review. Note - other age groups available: 2-4 years, 5-14 years, >15 years; also: PCV7 type only, PCV 13 type only, NVT, and all-type. Data here (PCV13 type , under 2) show highest impact. BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
  • 32. Board meeting 2-3 December 2015 Hospital admissions for diarrhoea before and after rotavirus vaccine introduction, Rwanda Ngabo F et al. Effect of pentavalent rotavirus vaccine introduction on hospital admissions for diarrhea and rotavirus in children in Rwanda: a time-series analysis. Lancet Global Health, in press. BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
  • 33. Board meeting 2-3 December 2015 Vaccine stockpiles Cameroon: first Gavi-funded doses from OCV stockpile BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
  • 34. Board meeting 2-3 December 2015 Vaccine stockpiles Niger: meningitis A,C,Y,W conjugate vaccine stockpile BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
  • 36. Board meeting 2-3 December 2015 Mission indicators BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
  • 37. Board meeting 2-3 December 2015 Vaccine goal indicators: country introductions BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
  • 38. Board meeting 2-3 December 2015 15 28 57 Vaccine goal indicators: coverage BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
  • 39. Board meeting 2-3 December 2015 Health systems goal indicators BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
  • 40. Board meeting 2-3 December 2015 All key performance indicators available online www.gavi.org/results/goal-level-indicators/ BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
  • 41. Board meeting 2-3 December 2015 First four countries transitioning from Gavi support, 31 December 2015 Honduras Sri Lanka Bhutan Mongolia BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
  • 43. Board meeting 2-3 December 2015 Our main tasks 2016-2020  Maintain momentum of vaccine introductions  Increase coverage and equity  Strengthen routine immunisation  Ensure sustainability BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
  • 44. Board meeting 2-3 December 2015 Finish the job: continued focus on vaccine introductions 2011 2012 2013 2014 2015 >220 introductions 20162017 2018 2019 2020 >220 introductions Sources: Vaccine Implementation data as of 15 September 2015. Unconstrained introduction dates used for all vaccines except yellow fever and rotavirus vaccines. BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
  • 45. Board meeting 2-3 December 2015 Immunisation coverage in 73 Gavi-supported countries Coverage with three doses of DTP-containing vaccine Source: WHO/UNICEF Estimates of National Immunization Coverage, 2015. BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
  • 46. Board meeting 2-3 December 2015 A closer look BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
  • 47. Board meeting 2-3 December 2015 100% Measles-containing vaccine 1st dose Pentavalent vaccine Measles-containing vaccine 2nd dose Yellow fever vaccinea Pneumococcal vaccine Rotavirus vaccine Rubella vaccine HPV vaccineb Coverage by vaccine (%) Immunisation coverage in Gavi-supported countries Coverage refers to the final dose of each vaccine, unless otherwise stated. a Target population and coverage estimates are based on 32 yellow fever-endemic Gavi-supported countries in Africa. b Target population for HPV is 10 year old girls. Source: Gavi strategic demand forecast version 12. 70 77 45 83 86 56 80 51 21 20 2 72 48 53 39 79 by 2015 by 2020 Projections BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
  • 48. Board meeting 2-3 December 2015 17 countries 13 countries 4 countries 14 countries 11 countries 12 countries < 50% 50-59% 60-69% 70-79% 80-89% > 90% Routine immunisation coverage has increased rapidly in many Gavi countries 1999 2004 2009 2014 Routine immunisation coverage BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
  • 49. Board meeting 2-3 December 2015 8 countries 5 countries 13 countries 15 countries 15 countries 16 countries < 50% 50-59% 60-69% 70-79% 80-89% > 90% Routine immunisation coverage has increased rapidly in many Gavi countries 1999 2004 2009 2014 Routine immunisation coverage BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
  • 50. Board meeting 2-3 December 2015 3 countries 2 countries 6 countries 16 countries 17 countries 28 countries < 50% 50-59% 60-69% 70-79% 80-89% > 90% Routine immunisation coverage has increased rapidly in many Gavi countries 1999 2004 2009 2014 Routine immunisation coverage BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
  • 51. Board meeting 2-3 December 2015 BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP < 50% 50-59% 60-69% 70-79% 80-89% > 90% 5 countries 2 countries 4 countries 14 countries 16 countries 32 countries Routine immunisation coverage has increased rapidly in many Gavi countries 1999 2004 2009 2014 Routine immunisation coverage
  • 52. Board meeting 2-3 December 2015 < 50% 50-59% 60-69% 70-79% 80-89% > 90% “Ceiling effect” as coverage increases Routine immunisation coverage 20 15 10 5 0 25 Average%changein5yearperiod Average percentage point change in five-year period by baseline coverage level, third dose DTP-containing vaccine BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
  • 53. Board meeting 2-3 December 2015 New country-focused approach to deliver on our strategy, 2016-2020 Aligned, integrated and holistic package of support for countries Partners’ Engagement Framework including targeted country assistance Prioritisation: intensified focus on 20 countries Cross-cutting strategic focus areas BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
  • 54. Board meeting 2-3 December 2015 20 priority countries Representing 75% of under-immunised children in Gavi countries 10 countries most under-immunised children BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP 10 countries high inequities1 or conflict 1 High inequity is defined as >20% coverage difference between highest and lowest wealth quintile in DHS surveys after 2010. N/A
  • 55. Board meeting 2-3 December 2015 Priority country: India • Coverage: world’s largest number of under-immunised children • Equity: poorest states have similar income levels to poorest Gavi-supported countries • Catalytic partnership to launch pneumococcal, rotavirus, rubella, human papillomavirus vaccines “India’s rich experience in universal immunization and particularly its experience this year with the Mission Indradhanush could be shared with all countries.” -- Narendra Modi, Indian Prime Minister Mission Indradhanush: building on Gavi HSS grant to mainstream polio resources into routine immunisation BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
  • 56. Board meeting 2-3 December 2015 Gavi’s investment per child in the 15 Gavi- eligible countries with the biggest birth cohorts - 50 100 150 200 250 300 0 500,000 1,000,000 1,500,000 2,000,000 2,500,000 3,000,000 3,500,000 4,000,000 4,500,000 Children under-immunised with DTP3 in 2014 Gaviinvestmentperchild(US$) India Nigeria Pakistan Indonesia Ethiopia Congo, DR Kenya Afghanistan Tanzania Bangladesh Angola Sudan (the) Uganda Mozambique Vietnam
  • 57. Board meeting 2-3 December 2015 Priority country: Madagascar Intensification of activities for coverage & equity Supply chain Human resources Service delivery & community Data & planning Financing Rapid deployment of solar-drive fridges in all health centres Increased staffing in Centres de Santé de Base Health worker training Outreach and micro-planning Community mobilisation through health workers Increased availability of data collection tools (registries, vaccination cards) Redesigned data flow Advocating for sufficient financing ISSUESSOLUTIONS BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
  • 58. Board meeting 2-3 December 2015 Technical assistance package Application guidelines Technology guide for decision makers Advocacy and communications 5-10 countries expected to apply in 2016 (NOT EXHAUSTIVE) BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP Cold Chain Equipment Platform: launch preparations
  • 59. Board meeting 2-3 December 2015 Vaccine- preventable disease surveillance Proposed approach to data: what the Alliance aims to achieve by 2020 Goals for 2020 Focus areas Strengthen country surveillance systems & create networks Identify AEFI & investigate, respond efficiently and effectively and address public concerns Improve the availability, quality, use of data & strengthen health workforce data use capability BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP Data for Immunisation Delivery, Coverage & Equity (DCE) Vaccine safety
  • 60. Board meeting 2-3 December 2015 Sustainability: 21 countries in accelerated transition phase Countries in accelerated transition phase Set to become fully self-financing from 2016Note: Cuba and the Ukraine are no longer receiving Gavi vaccine support. BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
  • 62. Board meeting 2-3 December 2015 Improving the way we work: examples • Risk management: new organisational structure, dedicated risk function, new Head of Risk • Knowledge management: country portal facilitating communications between countries and partners • Simplification: eg revised programme funding policy • Grant management: streamlining disbursement and review processes • Human resources: performance and talent management BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
  • 63. Board meeting 2-3 December 2015 Streamlining Board documentation June 2015: 608 pages + 9 additional documents on myGavi December 2015: 466 pages, no additional documents on myGavi myGavi: not just Board meeting documents and presentations, but also: • Up-to-date calendar of all Board and Board Committee meetings • Up-to-date list of all Board and Board Committee members • Statutes, by-laws and committee charters • Board member reference book • Policy handbook • Quarterly risk report and risk register
  • 64. Board meeting 2-3 December 2015 Partners’ Engagement Framework in action: Afghanistan • Enhanced national capacity: 4 of 6 national officers moved from partner offices to health ministry • Stronger alignment: less duplication between partners, more harmonised support • More transparent: country has visibility on Gavi-funded support (limited insight into partners’ submissions) • More targeted: added support from new partner to build financial management capacity (country priority) • Increased value for money: 23% reduction in budget with reduced spend on travel and consulting BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
  • 65. Board meeting 2-3 December 2015 Strengthened grant management: responding to Yemen crisis • Tailoring support to countries • Re-allocation: HSS funds rapidly re-allocated to support integrated outreach • Result: 1,900 mobile teams reached 70,000 children in September • Going forward: continued use of funds for integrated outreach, channelled through partners BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
  • 66. Board meeting 2-3 December 2015 Gavi recognised for country engagement A Snapshot of Development Partner Communication and Performance (October 2015) Based on interviews with 6,750 policymakers and practitioners in 126 low- and middle-income countries BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
  • 67. Board meeting 2-3 December 2015 Eight areas of potential collaboration between Gavi and the Global Fund BIGGER PICTURE RECENT UPDATES 2011-2015 RESULTS 2016-2020: RAISING OUR GAME GEARING UP Programmes Risk management Supply chain Non-vaccine procurement Monitoring, evaluation & data Resource mobilisation Communications & advocacy Headquarters operations
  • 68. Board meeting 2-3 December 2015 Growing business: More proactive management of programmes & risk BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP 247 590 2011 2015 Number of doses per year (USD millions) 2x2 3 1 4 6 12 2011 2015 Number of vaccines supported 2x 68 372 2011 2015 Cash grants disbursement per year (USD millions) 5x 150 470 2011 2015 Number of active grants (vaccines and cash) 3x
  • 69. Board meeting 2-3 December 2015 Board retreat in Beijing, China, April 2016 BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP • dd
  • 70. Board meeting 2-3 December 2015 Adapting to the frictionless economy BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
  • 71. Board meeting 2-3 December 2015 Adapting to the frictionless economy? BIGGER PICTURE GAVI UPDATES 2011-2015 RESULTS 2016-2020 REACHING EVERY CHILD GEARING UP
  • 73. Board meeting 2-3 December 2015 From President Kikwete…. To private citizen Kikwete….
  • 74. Board meeting 2-3 December 2015 Special Envoy Høybråten